FDA “People Power” Could Take Sequestration Hit – Hamburg
This article was originally published in The Rose Sheet
Executive Summary
FDA’s commissioner says allowing the budget sequester would slow implementation of FDA Safety and Innovation Act provisions and reduce some overseas inspections. More emphasis could be placed on using systems that target the riskiest facilities to reduce the number of onsite inspections, Commissioner Hamburg says.